It's How Medicine Should Be®

Font Size:

-A +A

Translate

French German Italian Portuguese Russian

Pre-Menopausal Heavy Uterine Bleeding and Uterine Fibroids Study

Clinical Trial Protocol ID: 
11081503
Clinical Trial Investigator Name: 
Barbara Soltes, MD

The purpose of this study is to determine the efficacy of an oral investigational medication to decrease frequency and amount of uterine bleeding as well as size or volume of uterine fibroids.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Have a diagnosis of uterine fibroids
  • Have heavy uterine bleeding during menstrual cycles
  • Are a pre-menopausal women 20 years of age or older

You will be excluded from this study if you:

  • Have endometriosis
  • Have osteoporosis
  • Are currently using any corticosteroid

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Contact Name: 
Carol Miller
Contact Phone: 
(312) 563-2611